Clinical trial
Effects of Major Ozone Autohemotherapy on Sarcopenia Parameters and Clinical Features in Fibromyalgia
NCT07680621 is registered in ClinicalTrials.gov with Sakarya University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Major Ozone Autohemotherapy on Sarcopenia Parameters and Clinical Features in Fibromyalgia
- Lead sponsor
- Sakarya University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- August 31, 2026
- Completion date
- March 31, 2027
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.